Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Drutz | M | 86 | 7 years | |
| Pete Petit | M | 84 | 9 years | |
| Robert P. Ruscher | M | 64 | 4 years | |
| Carolyn J. Logan | F | 75 | 15 years | |
| John F. Chappell | M | 86 | 22 years | |
| Timothy J. Creech | M | 63 | 8 years | |
| Fred Davenport | M | 72 |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 10 years |
| William S. Poole | M | 77 | 9 years | |
| Paul H. Fischer | M | 74 | 17 years | |
| Scott M. Plesha | M | 59 | 22 years | |
| Mark Sirgo | M | 70 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 11 years |
| James McNulty | M | 73 | 14 years | |
| Joseph Lockhart | M | - | 14 years | |
| Albert Medwar | M | - | 11 years | |
| Ernest de Paolantonio | M | 70 | 6 years | |
| Robert Rosewell Chai-Onn | M | 52 | - | |
| John Didsbury | M | 68 | 1 years | |
| Ann A. Rosar | F | 72 | - | |
| Haywood D. Cochrane | M | 75 | - | |
| David Blum | M | - | - | |
| Fred Eshelman | M | 76 |
Glaxo, Inc.
| - |
| Fredrick Frank | M | 92 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
| David Savello | M | 78 |
Glaxo, Inc.
| 12 years |
| Kevin Kotler | M | 53 | 4 years | |
| Todd Davis | M | 63 | 4 years | |
| Santo Costa | M | 78 |
Glaxo, Inc.
| 7 years |
| Peter J. Wise | M | 89 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 3 years |
| Adam C. Derbyshire | M | 58 | 14 years | |
| Richard A. Franco | M | 82 | - | |
| Mary Coleman | F | - | - | |
| Kurt M. Eichler | M | 66 | 4 years | |
| Andrew K. Rooke | M | 40 | 3 years | |
| Peter Greenleaf | M | 54 | 4 years | |
| William Watson | M | 73 | 5 years | |
| Niraj Vasisht | M | 61 | 13 years | |
| Samuel Sears | M | 80 | 7 years | |
| John J. Shea | M | 97 | 13 years | |
| James D. Darnley | M | - | 1 years | |
| Herm Cukier | M | 57 | 2 years | |
| Lorin Johnson | M | 71 | 13 years | |
| Tim Tyson | M | 71 | 2 years | |
| William P. Keane | M | 68 | 11 years | |
| Larry Papasan | M | 84 | 11 years | |
| Randy W. Hamilton | M | - | 9 years | |
| William Bertrand | M | 59 | 2 years | |
| Charles Bramlage | M | 63 | 3 years | |
| Sarah DeRossett | M | - | 1 years | |
| Barry I. Feinberg | M | 68 | 4 years | |
| William B. Stone | M | 81 | 16 years | |
| John L. Gainer | M | 85 |
University of Delaware
| 3 years |
| Lee Babiss | M | 68 |
Glaxo, Inc.
| 3 years |
| Robert H. Murdock | M | - | 1 years | |
| Jordan Zwick | M | 37 | 6 years | |
| Kyle Feldman | F | - | 2 years | |
| David Wasserman | M | - | 3 years | |
| John Josey | M | 63 |
Glaxo, Inc.
| 4 years |
| Gerard M. McGeehan | M | - |
Glaxo, Inc.
| - |
| Andrew Barrett | M | - | 3 years | |
| John C. Crelling | M | - |
University of Delaware
| - |
| Michael J. Culumber | M | - | 2 years | |
| Matthew Casbon | M | - | 5 years | |
| Charles Dadswell | M | 65 | 2 years | |
| Imre Kovesdi | M | - | - | |
| Michael Bullock | M | - | 3 years | |
| Arthur Coury | M | - |
University of Delaware
| 4 years |
| Penelope J. Bucknell | F | - |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 10 years |
| Stephana Patton | M | 54 | 8 years | |
| J. Pearson | M | 64 | - | |
| George Ng | M | 49 | 3 years | |
| John F. Porter | M | - |
University of Delaware
| 2 years |
| Rick Scruggs | M | 64 | 15 years | |
| Herbert Conrad | M | 91 | 7 years | |
| Alan A. Steigrod | M | 86 |
Glaxo, Inc.
| 10 years |
| William Harral | M | 84 | 4 years | |
| Don Harrison | M | 90 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 2 years |
| W. Staub | M | 61 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 7 years |
| Hamilton W. Jordan | M | 80 | - | |
| Arthur R. Kamm | M | - | - | |
| Stephen D. Celestini | M | - | 5 years | |
| Geert Cauwenbergh | M | 70 | 2 years | |
| David N. Taylor | M | 75 | - | |
| William Forbes | M | 62 | 10 years | |
| Channing Heard Russell | M | 76 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 2 years |
| Ronald G. Wallace | M | 79 | 1 years | |
| Douglas E. Brough | M | 69 | 24 years | |
| Brian Tuttle | M | - |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
| Patti S. Hart | F | 67 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 3 years |
| Andrew L. Finn | M | 75 | 11 years | |
| Steven C. Mayer | M | 70 | 1 years | |
| Paul Blake | M | 76 | - | |
| Peter L. Ginsberg | M | 58 | - | |
| Jim P. Foster | M | - |
University of Delaware
| 4 years |
| Charlie Sanders | M | 91 |
Glaxo, Inc.
| 6 years |
| Stuart McWhorter | M | 55 | - | |
| Philip Leon Gould | M | - |
Glaxo, Inc.
| - |
| Dennis J. Donohoe | M | 72 |
Glaxo, Inc.
| 1 years |
| Andrew H. Strayer | M | - |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
| Mark W. Salyer | M | - | - | |
| Chuck Koob | M | 79 | 12 years | |
| Mark Watson | M | 74 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 90.00% |
| Canada | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas D'Alonzo
- Personal Network
